The Catalyst

Most Recent Posts

04.01.11 | By Kate Connors

Perhaps you've seen John Mack's April Fool's post that says he's gotten a copy of PhRMA's "statement" on the Food and Drug Administration's delayed social media guidelines.

Mack's post, which presents a fictitious statement, has made the rounds this morning, underscoring the immediacy of social media.

04.01.11 | By Kate Connors

Recently I wrote about the winner of the PhRMA Foundation Award in Excellence, Bryan l. Roth, PhD, from University of North Carolina Chapel Hill.


This story in the LA Times caught my eye today. It talks about how two experimental drugs now being tested have the potential for transforming Hepatitis C - a deadly liver disease - into a more manageable chronic condition.


When the Medicare prescription drug program (Part D) started providing substantial savings to millions of seniors and disabled Americans, AARP publicly stated that "many [seniors] who choose the least expensive Medicare drug plan in their area that covers a


There was good advice in an article in the Washington Post health section. It encouraged readers to get their blood pressure checked to detect hypertension and the potential for heart disease.

03.30.11 | By John Castellani

Wherever I have worked, I've been impressed by colleagues who find the time in their otherwise busy lives to volunteer to help those in need. Their efforts to give back to the community and improve the lives of their neighbors is an inspiration. It reminds us all to take the time and look up from our work-a-day lives and to think about what we might do to help reach out to our neighbors in need and make our community a better place to live.

03.30.11 | By Kate Connors

Today is PhRMA's "Day of Service." We all have a lot on our plates, as always, but we'll be turning off our computers, setting our phones with an away message, changing into jeans, and spending the day giving back to the community.

For this day of service, we'll be going to a local elementary school here in DC to help get their playground ready for spring and to paint healthy living murals in their gymnasium.

03.29.11 | By Kate Connors

Today - as I told you yesterday - PhRMA released the results of an opinion survey of more than 500 physicians regarding their interactions with biopharmaceutical research companies.

I won't rehash the entire results of the survey in this post, as you can read the survey itself if you wish.


Once again, AARP has released a report on the prices of medicines that distorts the reality of the marketplace. This time around, AARP took its same market basket of medicines it has used since 2006 and analyzed solely the prices for brand name drugs, excluding generics entirely.


Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc pharetra dui vitae risus vulputate at cursus leo condimentum. Maecenas aliquam risus a arcu tempor accumsan. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Mauris sit amet erat risus, quis auctor orci. Integer ac diam et nisl consectetur rutrum. Ut tempor, nisi eu aliquet pulvinar, nisl purus luctus dui, eget scelerisque mauris lacus id diam. Nam purus libero, elementum sed egestas in, iaculis nec ligula.

03.28.11 | By Kate Connors

Recently, there has been a spate of misleading media coverage about interactions between biopharmaceutical company representatives and healthcare providers.

In various ways, the bulk of this coverage has depicted these relationships in a negative light, one that is both biased and outdated.

I'd like to take a moment here to explain the value of engagement between companies and give a second opinion, so to speak.


I won't even try to compete with Kate's masterful Friday wrap-up piece. But, stepping in this afternoon because Kate is off somewhere "working" (a likely story) on something that has to be done today, here are a couple of things I saw in the media over the last couple of days that caught my eye and that I wanted to share.

03.25.11 | By Kate Connors

On The Catalyst, Grady and I write often, and generally, about the researchers - be they government-funded, academic, or with biopharmaceutical companies - that create America's collaborative research ecosystem. Today, we get to know one a little bit better.

This Wednesday, the PhRMA Foundation announced the recipient of its Award in Excellent in Pharmacology/Toxicology, naming University of North Carolina at Chapel Hill School of Medicine professor Bryan L. Roth, PhD.


Angie Drakulich over at PharmTech had a nice blog post yesterday where, among other things, she mentioned the great work the Rx Response coalition has done in helping U.S. government response to the crisis in Japan.